FivePlus Gene Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

FivePlus Gene General Information

Description

Provider of viral vector production services created to accelerate the commercialization of gene therapy in China. The company focuses on the innovative research and development of viral vector technology, its business covers the preparation of gene medicines from early R&D and new drug clinical trial application (pre-IND), and provides customers in the gene therapy field with integrated CDMO solutions from process development, pilot trials, and clinical sample production, enabling the patients to get access to effective and affordable gene drugs.

Contact Information

Website
www.fiveplusgene.com.cn
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Building 25, No.50 Huatuo Road, Daxing Biomedical Industry Base
  • Zhongguancun Science Park, Daxing District
  • Beijing
  • China
+86 010
Primary Industry
Pharmaceuticals
Parent Company
GeneCradle
Vertical(s)
Life Sciences
Corporate Office
  • Building 25, No.50 Huatuo Road, Daxing Biomedical Industry Base
  • Zhongguancun Science Park, Daxing District
  • Beijing
  • China
+86 010

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FivePlus Gene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Jun-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 28-Sep-2021 Completed Generating Revenue
2. Early Stage VC 21-Feb-2021 Completed Generating Revenue
1. Early Stage VC 21-Nov-2019 Completed Generating Revenue
To view FivePlus Gene’s complete valuation and funding history, request access »

FivePlus Gene Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ao Peng Investment PE/Buyout Minority
Beijing Daxing Investment Group Government Minority
HJ-Investment Venture Capital Minority
Yizhuang Guotou Venture Capital Minority
To view FivePlus Gene’s complete investors history, request access »

Ready to get started?

Request a free trial

FivePlus Gene FAQs

  • When was FivePlus Gene founded?

    FivePlus Gene was founded in 2018.

  • Where is FivePlus Gene headquartered?

    FivePlus Gene is headquartered in Beijing, China.

  • What industry is FivePlus Gene in?

    FivePlus Gene’s primary industry is Pharmaceuticals.

  • Is FivePlus Gene a private or public company?

    FivePlus Gene is a Private company.

  • What is FivePlus Gene’s current revenue?

    The current revenue for FivePlus Gene is .

  • Who are FivePlus Gene’s investors?

    Ao Peng Investment, Beijing Daxing Investment Group, HJ-Investment, and Yizhuang Guotou have invested in FivePlus Gene.

  • When was FivePlus Gene acquired?

    FivePlus Gene was acquired on 15-Jun-2023.

  • Who acquired FivePlus Gene?

    FivePlus Gene was acquired by GeneCradle.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process